ENDO 2010 Annual Meeting - Includes 5 Complimentary Sessions
Click here to go to the previous page
TRANSLATIONAL - Molecularly-Targeted Therapies for Endocrine Tumors
Program Code:
S17
Date:
Saturday, June 19, 2010
Time:
3:45 PM to 5:15 PM
EST
SPEAKER
(S):
Shlomo Melmed, MD, Cedars-Sinai Med Ctr, Los Angeles, CA
Disclosure: Nothing to Disclose
Steven I. Sherman, MD, Univ of Texas MD Anderson Cancer Ctr, Houston, TX
Disclosure: Investigator, Amgen, AstraZeneca, Genzyme Corporation; Advisory Group Member, AstraZeneca; Consultant, Bayer, Inc., Celgene, Lilly USA, LLC, Oxigene, Exelixis, Plexxikon, Semafore.; Speaker, Genzyme Corporation.
No items are available for this session.